Nomenclature & Taxonomic Classification
- Botanical Binomial: Bixa orellana L.
- Family: Bixaceae
- Common Name(s): Annatto, Achiote, Lipstick Tree, Urucum
- Parts Used: Seed and seed coat paste
Botanical Description, Habitat & Sustainability
- Physical Description:
- Growth Habit: Evergreen tropical shrub or small tree.
- Morphology: Grows to heights of 2 to 6 meters. Leaves are large, heart-shaped, and glossy green with reddish veins. Flowers are pink or white. The fruit is a heart-shaped, prickly, bright red-brown capsule containing up to 50 seeds embedded in a vivid red pulp.
- Habitat & Cultivation: Native to tropical regions of the Americas (Amazon basin). It thrives in full sun, well-draining tropical soils, and hot, humid lowland environments. Cultivated widely across the global tropics.
- Sustainability Status: Secure; abundant globally and cultivated as a major natural coloring agent for the food and cosmetics industries.
Energetics & Traditional Actions
- Western Tissue States: Cooling, astringent, and mildly bitter. Corrects Irritation (heat) and Relaxation (leaking structural tissues).
- Traditional Vector:
- Ayurveda: Rasa (Taste): Bitter, Astringent | Virya (Energy): Cooling | Vipaka (Post-Digestive Effect): Pungent | Dosha Modulation: Reduces Pitta and Kapha.
- Traditional Chinese Medicine: Temperature: Cool | Taste: Bitter, Sweet | Organ Meridians Entered: Liver, Heart, Bladder.
- Historical Folk Use: Extensively used by Indigenous peoples of Central and South America to protect the skin from sun and insects, cool heat, calm burning conditions, and balance blood conditions.
Phytochemistry & Pharmacological Dynamics
- Primary Phytochemicals: Carotenoids (primarily fat-soluble bixin and water-soluble norbixin), apocarotenoids, tocotrienols, terpenoids, and flavonoids.
- Mechanism of Action:Bixin and norbixin fractions function as high-potency singlet oxygen scavengers, suppressing lipid peroxidation cascades across cellular and vascular membranes. Norbixin exhibits free radical scavenging capacities and acts down-stream to modulate inflammatory responses by blocking nuclear factor-kappa B (NF-κB) nuclear translocations.
Clinical Applications & Indications
- Primary Indications: Systemic oxidative stress support, supportive care in mild hypertension, and inflammatory dermatological conditions requiring antioxidant reinforcement.
- Secondary Indications: Historically used as a digestive carminative for mild dysentery and as a topical skin protectant.
- Modern Clinical Evidence: Modern pharmacology focused on Bixa orellana isolates supports its strong antioxidant, hypolipidemic, and anti-inflammatory properties in animal and metabolic models.
Preparation, Dosing & Extraction Matrix
- Optimal Menstruum & Extraction Guidelines: Lipids or high-proof ethanol for the bixin fraction (bixin is highly lipid-soluble); aqueous infusions successfully extract the water-soluble norbixin fraction.
Standard Dosage Parameters
| Delivery Method | Standard Clinical Dosage | Frequency / Administration |
| Culinary Paste / Powder | 1–2 grams daily | Incorporated directly into dietary lipids |
| Infusion (Seeds) | 1 teaspoon of dried seeds per cup of boiling water | Steeped covered for 15 minutes, taken twice daily |
| Tincture (1:5) | 2–3 mL | Taken twice daily in water |
Safety Profile, Contraindications & Drug Interactions
- Contraindications: Avoid high therapeutic doses during pregnancy due to a lack of safety data.
- Side Effects & Toxicity Thresholds: Exceptionally safe at normal dietary inputs; rare instances of localized allergic contact potential have been documented.
- Pharmaceutical Cross-Interactions:
- Enzyme Alterations: No major clinical interactions noted on CYP450 enzymes.
- Additive Pathways: May display mild additive or synergistic effects when combined with pharmaceutical hypoglycemic or antihypertensive medications.
References
- Lorenzi, H., & Matos, F. J. A. Plantas Medicinais no Brasil, Instituto Plantarum, 2002.
- Junior, A. C., et al. “Biological and pharmacological activities of Bixa orellana L.” Journal of Ethnopharmacology, 144(3), 469-484, 2012.